Variant report
Variant | rs971965 |
---|---|
Chromosome Location | chr5:61561921-61561922 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:13)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:61539663..61541258-chr5:61560288..61563274,2 | K562 | blood: | |
2 | chr5:61550007..61554674-chr5:61558868..61565665,10 | K562 | blood: | |
3 | chr5:61560375..61564102-chr5:61592918..61596892,3 | K562 | blood: | |
4 | chr5:61561722..61564557-chr5:61699479..61701538,2 | K562 | blood: | |
5 | chr5:61561395..61563266-chr5:61628626..61630582,2 | K562 | blood: | |
6 | chr5:61560033..61563867-chr5:61600448..61603571,4 | K562 | blood: | |
7 | chr5:61560127..61563609-chr5:61600323..61607787,9 | K562 | blood: | |
8 | chr5:61560442..61563605-chr5:61575064..61578930,3 | K562 | blood: | |
9 | chr5:61561863..61563479-chr5:61638036..61640734,2 | K562 | blood: | |
10 | chr5:61560127..61563309-chr5:61603579..61607776,4 | K562 | blood: | |
11 | chr5:61561179..61563178-chr5:61595838..61598010,2 | K562 | blood: | |
12 | chr5:61539494..61542163-chr5:61560247..61562435,2 | K562 | blood: | |
13 | chr5:61561783..61565148-chr5:61601604..61603284,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000086200 | Chromatin interaction |
ENSG00000086189 | Chromatin interaction |
ENSG00000068796 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1108158 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11740652 | 0.83[ASN][1000 genomes] |
rs11742167 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11747516 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs11750109 | 0.87[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs12655562 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs13155253 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs13156073 | 0.90[CHB][hapmap];1.00[JPT][hapmap] |
rs13156695 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs13161789 | 1.00[AMR][1000 genomes];0.96[EUR][1000 genomes] |
rs13162519 | 1.00[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs13162821 | 0.87[AMR][1000 genomes];0.96[EUR][1000 genomes] |
rs13169321 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs13170425 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13174779 | 0.83[ASN][1000 genomes] |
rs13176923 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs13178729 | 0.87[AMR][1000 genomes] |
rs13181377 | 1.00[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs13189446 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs153860 | 0.90[CHB][hapmap] |
rs153864 | 1.00[CHB][hapmap];0.89[CHD][hapmap];1.00[GIH][hapmap];1.00[MEX][hapmap];0.82[TSI][hapmap] |
rs153866 | 0.90[CHB][hapmap] |
rs153869 | 0.90[CHB][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap] |
rs153873 | 0.90[CHB][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap] |
rs16875037 | 0.83[ASN][1000 genomes] |
rs16890613 | 1.00[CHB][hapmap];0.89[JPT][hapmap];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs16890618 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs16890628 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs16890634 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];0.94[TSI][hapmap];0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs16890651 | 0.90[CHB][hapmap];0.94[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.88[TSI][hapmap];0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs16898838 | 0.87[AMR][1000 genomes];0.96[EUR][1000 genomes] |
rs2059162 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2063255 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2272291 | 0.90[CHB][hapmap];0.84[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.94[TSI][hapmap] |
rs2441115 | 0.90[CHB][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap] |
rs27090 | 0.90[CHB][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap] |
rs34220654 | 0.83[ASN][1000 genomes] |
rs34596001 | 0.83[ASN][1000 genomes] |
rs35011 | 0.89[CHB][hapmap] |
rs35012 | 0.88[CHB][hapmap] |
rs35058 | 0.90[CHB][hapmap] |
rs35238667 | 0.83[ASN][1000 genomes] |
rs35311093 | 1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs35572300 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs35672643 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs35699711 | 0.87[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs35744020 | 1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs35746052 | 1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs35794032 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs35808056 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs35842742 | 1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs36105063 | 1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs3776612 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs3776614 | 0.87[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs3822487 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.83[ASN][1000 genomes] |
rs4289514 | 0.83[ASN][1000 genomes] |
rs71617425 | 1.00[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs71617426 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs71617427 | 1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs71617428 | 0.87[AMR][1000 genomes];0.92[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs7446543 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs814169 | 1.00[CHB][hapmap];0.89[CHD][hapmap];1.00[GIH][hapmap];1.00[MEX][hapmap];0.82[TSI][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1024090 | chr5:61258759-61921150 | Flanking Active TSS Enhancers Weak transcription Strong transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
2 | esv2757996 | chr5:61403138-61687817 | Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 10 gene(s) | inside rSNPs | diseases |
3 | esv2759345 | chr5:61403138-61748912 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
4 | nsv830318 | chr5:61415713-61623320 | Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
5 | nsv1020255 | chr5:61451792-62031365 | Strong transcription Enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
6 | nsv1027539 | chr5:61457762-62000008 | Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
7 | esv2755585 | chr5:61535831-61618595 | Enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive region | 7 gene(s) | inside rSNPs | diseases |
8 | nsv881726 | chr5:61556730-61676911 | Flanking Active TSS Weak transcription Enhancers Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive region | 7 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:61557800-61563400 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
2 | chr5:61558400-61564200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
3 | chr5:61560800-61564400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr5:61561000-61562600 | Enhancers | Brain Germinal Matrix | brain |
5 | chr5:61561200-61562600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr5:61561400-61563400 | Enhancers | K562 | blood |
7 | chr5:61561600-61564400 | Weak transcription | Primary hematopoietic stem cells | blood |